Amoxycillin & Potassium Clavulanic Injection IP – Moxival CL 1.2 Injection

Moxival CL 1.2 Injection – Broad-Spectrum Efficacy With Dual Action. Single Purpose – Eradicating Infection.

Moxival CL 1.2 Injection – The dual composition of Amoxycillin & Potassium Clavulanic Injection IP is a fixed-dose combination of Amoxicillin and Clavulanic acid designed to treat bacterial infections caused by beta-lactamase-producing organisms.
Amoxicillin disrupts bacterial cell wall synthesis, while Clavulanic acid inhibits beta-lactamase enzymes, preventing antibiotic degradation and extending the antimicrobial spectrum.

Key Benefits of Amoxycillin & Potassium Clavulanic Injection IP – Moxival CL 1.2 Injection
✅ Broad-Spectrum Coverage with Beta-Lactamase Protection – Combines Amoxicillin’s bactericidal activity with Clavulanic acid’s enzyme inhibition for enhanced effectiveness against resistant strains.
✅ Daily Dosing for Patient Compliance – To improving patient adherence without comprising therapeutic efficacy which help to maintains steady blood flow throughout the body.
✅ Clinical Efficacy with Good Tolerability – Proven therapeutic success with excellent absorption and gastrointestinal tolerance in both outpatient and hospital settings.

Recommended By Specialists:
👨‍⚕️ General Physician: It should mainly used to prefer to treat the disease associated with urinary tract infections, skin infections, or mixed bacterial infections.
👨‍⚕️ Pulmonologist: It should mainly used to differ to treat the disease associated for community-acquired pneumonia, bronchitis, or severe lower respiratory infections.
👨‍⚕️ Urologist: It should mainly used to prefer to treat the disease associated with complicated UTIs or kidney infections (pyelonephritis).

INDICATIONS:
✅ Upper & Lower Respiratory Tract Infections
✅ Acute Bacterial Sinusitis
✅ Skin & Soft Tissue Infections
✅ Urinary Tract Infections
✅ Dental Infections
✅ Bone & Joint Infections